Nintedanib Reveals Remarkable Efficacy in Alleviating Progressive Pulmonary Fibrosis Symptoms
In the groundbreaking INBUILD trial, researchers discovered that nintedanib can significantly improve the lives of patients suffering from progressive pulmonary fibrosis (PPF). Nintedanib holds promise not only in reducing the progression of dyspnea, fatigue, and cough but also in mitigating the overall impact of ILD over 52 weeks in patients grappling with PPF. The trial […]